Cargando…

The diagnosis and management of Cushing's syndrome in pregnancy

Endogenous Cushing's syndrome (CS) is rarely encountered during pregnancy. Clinical and biochemical changes in healthy pregnancy overlap with those seen in pregnancy complicated by CS; the diagnosis is therefore challenging and can be delayed. During normal gestation, adrenocorticotrophic hormo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamblin, Ross, Coulden, Amy, Fountas, Athanasios, Karavitaki, Niki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541401/
https://www.ncbi.nlm.nih.gov/pubmed/35491087
http://dx.doi.org/10.1111/jne.13118
_version_ 1784803916019400704
author Hamblin, Ross
Coulden, Amy
Fountas, Athanasios
Karavitaki, Niki
author_facet Hamblin, Ross
Coulden, Amy
Fountas, Athanasios
Karavitaki, Niki
author_sort Hamblin, Ross
collection PubMed
description Endogenous Cushing's syndrome (CS) is rarely encountered during pregnancy. Clinical and biochemical changes in healthy pregnancy overlap with those seen in pregnancy complicated by CS; the diagnosis is therefore challenging and can be delayed. During normal gestation, adrenocorticotrophic hormone, corticotrophin‐releasing hormone, cortisol, and urinary free cortisol levels rise. Dexamethasone administration fails to fully suppress cortisol in pregnant women without CS. Localisation may be hindered by non‐suppressed adrenocorticotrophic hormone levels in a large proportion of those with adrenal CS; smaller corticotroph adenomas may go undetected as a result of a lack of contrast administration or the presence of pituitary hyperplasia; and inferior petrosal sinus sampling is not recommended given the risk of radiation and thrombosis. Yet, diagnosis is essential; active disease is associated with multiple insults to both maternal and foetal health, and those cured may normalise the risk of maternal–foetal complications. The published literature consists mostly of case reports or small case series affected by publication bias, heterogeneous definitions of maternal or foetal outcomes or lack of detail on severity of hypercortisolism. Consequently, conclusive recommendations, or a standardised management approach for all, cannot be made. Management is highly individualised: the decision for surgery, medical control of hypercortisolism or adoption of a conservative approach is dependent on the timing of diagnosis (respective to stage of gestation), the ability to localise the tumour, severity of CS, pre‐existing maternal comorbidity, and, ultimately, patient choice. Close communication is a necessity with the patient placed at the centre of all decisions, with risks, benefits, and uncertainties around any investigation and management carefully discussed. Care should be delivered by an experienced, multidisciplinary team, with the resources and expertise available to manage such a rare and challenging condition during pregnancy.
format Online
Article
Text
id pubmed-9541401
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95414012022-10-14 The diagnosis and management of Cushing's syndrome in pregnancy Hamblin, Ross Coulden, Amy Fountas, Athanasios Karavitaki, Niki J Neuroendocrinol Invited Reviews Endogenous Cushing's syndrome (CS) is rarely encountered during pregnancy. Clinical and biochemical changes in healthy pregnancy overlap with those seen in pregnancy complicated by CS; the diagnosis is therefore challenging and can be delayed. During normal gestation, adrenocorticotrophic hormone, corticotrophin‐releasing hormone, cortisol, and urinary free cortisol levels rise. Dexamethasone administration fails to fully suppress cortisol in pregnant women without CS. Localisation may be hindered by non‐suppressed adrenocorticotrophic hormone levels in a large proportion of those with adrenal CS; smaller corticotroph adenomas may go undetected as a result of a lack of contrast administration or the presence of pituitary hyperplasia; and inferior petrosal sinus sampling is not recommended given the risk of radiation and thrombosis. Yet, diagnosis is essential; active disease is associated with multiple insults to both maternal and foetal health, and those cured may normalise the risk of maternal–foetal complications. The published literature consists mostly of case reports or small case series affected by publication bias, heterogeneous definitions of maternal or foetal outcomes or lack of detail on severity of hypercortisolism. Consequently, conclusive recommendations, or a standardised management approach for all, cannot be made. Management is highly individualised: the decision for surgery, medical control of hypercortisolism or adoption of a conservative approach is dependent on the timing of diagnosis (respective to stage of gestation), the ability to localise the tumour, severity of CS, pre‐existing maternal comorbidity, and, ultimately, patient choice. Close communication is a necessity with the patient placed at the centre of all decisions, with risks, benefits, and uncertainties around any investigation and management carefully discussed. Care should be delivered by an experienced, multidisciplinary team, with the resources and expertise available to manage such a rare and challenging condition during pregnancy. John Wiley and Sons Inc. 2022-05-01 2022-08 /pmc/articles/PMC9541401/ /pubmed/35491087 http://dx.doi.org/10.1111/jne.13118 Text en © 2022 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Invited Reviews
Hamblin, Ross
Coulden, Amy
Fountas, Athanasios
Karavitaki, Niki
The diagnosis and management of Cushing's syndrome in pregnancy
title The diagnosis and management of Cushing's syndrome in pregnancy
title_full The diagnosis and management of Cushing's syndrome in pregnancy
title_fullStr The diagnosis and management of Cushing's syndrome in pregnancy
title_full_unstemmed The diagnosis and management of Cushing's syndrome in pregnancy
title_short The diagnosis and management of Cushing's syndrome in pregnancy
title_sort diagnosis and management of cushing's syndrome in pregnancy
topic Invited Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541401/
https://www.ncbi.nlm.nih.gov/pubmed/35491087
http://dx.doi.org/10.1111/jne.13118
work_keys_str_mv AT hamblinross thediagnosisandmanagementofcushingssyndromeinpregnancy
AT couldenamy thediagnosisandmanagementofcushingssyndromeinpregnancy
AT fountasathanasios thediagnosisandmanagementofcushingssyndromeinpregnancy
AT karavitakiniki thediagnosisandmanagementofcushingssyndromeinpregnancy
AT hamblinross diagnosisandmanagementofcushingssyndromeinpregnancy
AT couldenamy diagnosisandmanagementofcushingssyndromeinpregnancy
AT fountasathanasios diagnosisandmanagementofcushingssyndromeinpregnancy
AT karavitakiniki diagnosisandmanagementofcushingssyndromeinpregnancy